Health Care & Life Sciences » Pharmaceuticals | Jiangxi Fushine Pharmaceutical Co. Ltd.

Jiangxi Fushine Pharmaceutical Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
-
-
93,601.80
172,520.20
174,476.70
192,361.90
Depreciation, Depletion & Amortization
-
-
28,683.20
34,422.90
45,727.20
54,012.70
Other Funds
12,136.50
10,842.20
244,183.30
111,304.00
7,408.20
16,446.50
Funds from Operations
57,939.00
32,200.70
140,317.10
212,595.40
233,514.30
261,211.50
Changes in Working Capital
-
-
65,980.80
23,320.80
37,020.30
108,491.60
Net Operating Cash Flow
57,939.00
32,200.70
74,336.30
189,274.60
196,494.00
152,719.90
Capital Expenditures
75,600.30
51,862.30
73,744.50
81,335.50
98,394.90
Sale of Fixed Assets & Businesses
132.60
164.80
753.70
290.00
347.20
Purchase/Sale of Investments
170.40
98.60
-
172,743.00
47,276.90
Net Investing Cash Flow
75,297.30
50,598.90
72,270.80
278,286.50
94,940.90
Cash Dividends Paid - Total
-
-
21,600.00
36,000.00
56,005.10
Issuance/Reduction of Debt, Net
27,350.00
26,910.00
68,344.90
21,200.00
184,602.60
Net Financing Cash Flow
15,213.50
16,067.80
290,928.20
54,104.00
136,005.70
Net Change in Cash
2,144.70
2,330.40
292,962.40
31,210.20
234,476.00
Free Cash Flow
17,661.30
19,661.60
591.80
107,939.10
98,099.10
Deferred Taxes & Investment Tax Credit
-
-
1,082.70
2,620.00
13,431.20
1,609.50
Net Assets from Acquisitions
-
-
-
24,497.90
44,170.20
Other Sources
-
1,000.00
720.00
-
-
Exchange Rate Effect
-
-
31.30
3,697.70
3,082.70

About Jiangxi Fushine Pharmaceutical Co.

View Profile
Address
Junction of Yushan & Liyang
Jingdezhen Jiangxi 333000
China
Employees -
Website http://www.fushine.cn
Updated 07/08/2019
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of active pharmaceutical ingredient (API) and pharmaceutical intermediates. It focuses on penicillin and its API and intermediates, and carbapenem and its API and intermediates. The company was founded in December 2002 and is headquartered in Jingdezhen, China.